Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with a high fatality rate. Currently, chemotherapy is the major treatment option, but the clinical result is unsatisfactory.
A recent multiomic study has established a super-enhancer-target regulatory network for breast cancers, exposing new epigenetic targets for therapeutics, particularly in triple-negative breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results